Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Elizabeth, Imbert"'
Autor:
Lloyd A. C. Chapman, Margot Kushel, Sarah N. Cox, Ashley Scarborough, Caroline Cawley, Trang Q. Nguyen, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Elizabeth Imbert, Nathan C. Lo
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background COVID-19 outbreaks have occurred in homeless shelters across the US, highlighting an urgent need to identify the most effective infection control strategy to prevent future outbreaks. Methods We developed a microsimulation model o
Externí odkaz:
https://doaj.org/article/2bcef7b709e34795bc429a3a881bcb22
Autor:
Andrés Aranda-Díaz, Elizabeth Imbert, Sarah Strieff, Dave Graham-Squire, Jennifer L. Evans, Jamie Moore, Willi McFarland, Jonathan Fuchs, Margaret A. Handley, Margot Kushel
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Background People experiencing homelessness who live in congregate shelters are at high risk of SARS-CoV2 transmission and severe COVID-19. Current screening and response protocols using rRT-PCR in homeless shelters are expensive, require specialized
Externí odkaz:
https://doaj.org/article/224e6f17118a477e883a7b0fb925bacb
Publikováno v:
Journal of Medical Education and Curricular Development, Vol 8 (2021)
Problem: Medical students often feel unprepared to care for patients whose cultural backgrounds differ from their own. Programs in medical schools have begun to address health: inequities; however, interventions vary in intensity, effectiveness, and
Externí odkaz:
https://doaj.org/article/12f48287db1e4679a4c0c55aeefdd010
Autor:
Kelly A Johnson, Hideaki Okochi, Mireya Arreguin, Joseph Watabe, David V Glidden, Anindita Chattopadhyay, Elizabeth Imbert, Matthew D Hickey, Monica Gandhi, Matthew Spinelli
Publikováno v:
Clinical Infectious Diseases. 76:930-933
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59–20.14; P = .007). This sugges
Autor:
Matthew A Spinelli, Noelle Le Tourneau, David V Glidden, Ling Hsu, Matthew D Hickey, Elizabeth Imbert, Mireya Arreguin, Jennifer P Jain, Jon J Oskarsson, Susan P Buchbinder, Mallory O Johnson, Diane Havlir, Katerina A Christopoulos, Monica Gandhi
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 1
Background After coronavirus disease 2019 (COVID-19) shelter-in-place (SIP) orders, viral suppression (VS) rates initially decreased within a safety-net human immunodeficiency virus (HIV) clinic in San Francisco, particularly among people living with
Autor:
Kelly A, Johnson, Hideaki, Okochi, Mireya, Arreguin, Joseph, Watabe, David V, Glidden, Anindita, Chattopadhyay, Elizabeth, Imbert, Matthew D, Hickey, Monica, Gandhi, Matthew, Spinelli
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
We found that urine tenofovir (TFV) levels1500 ng/ml strongly predict virologic suppression among patients with HIV taking tenofovir alafenamide (TAF, OR 5.66; 95% CI 1.59-20.14; p = 0.007). This suggests an existing point-of-care assay developed for
Autor:
Temet M. McMichael, Karrie-Ann Toews, Cortland Lohff, Emily Mosites, Julie L. Self, Grace E Marx, Isaac Ghinai, Elizabeth Imbert, Martha P. Montgomery, Tom Andrews, Elizabeth A. Samuels
Publikováno v:
Am J Public Health
Objectives. To examine shelter characteristics and infection prevention practices in relation to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection point prevalence during universal testing at homeless shelters in the United State
Autor:
Matthew D Hickey, Elizabeth Imbert, Ayesha Appa, Jan Bing Del Rosario, Elizabeth Lynch, John Friend, Rodrigo Avila, Angelo Clemenzi-Allen, Elise D Riley, Monica Gandhi, Diane V Havlir
Publikováno v:
J Infect Dis
The Journal of infectious diseases, vol 226, iss Suppl 3
The Journal of infectious diseases, vol 226, iss Suppl 3
Background People with HIV experiencing homelessness have low rates of viral suppression, driven by sociostructural barriers and traditional care system limitations. Informed by the capability-opportunity-motivation-behavior (COM-B) model and patient
Autor:
Katerina A, Christopoulos, Janet, Grochowski, Francis, Mayorga-Munoz, Matthew D, Hickey, Elizabeth, Imbert, John D, Szumowski, Samantha, Dilworth, Jon, Oskarsson, Mary, Shiels, Diane, Havlir, Monica, Gandhi
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Long-acting injectable antiretroviral therapy (LAI-ART) is approved for treatment-naïve or experienced people living with HIV (PLWH) based on trials that only included participants with viral suppression. We performed the first LAI-ART demonstration
Autor:
Madellena Conte, Ingrid Eshun-Wilson, Monica Gandhi, Angelo Clemenzi-Allen, Elvin Geng, Elizabeth Imbert, Matthew D. Hickey, Diane V. Havlir
Publikováno v:
J Acquir Immune Defic Syndr
Background Homelessness and unstable housing (HUH) negatively impact care outcomes for people living with HIV (PLWH). To inform the design of a clinic program for PLWH experiencing HUH, we quantified patient preferences and trade-offs across multiple